PKC-Dependent Signaling Pathways within PAG and Thalamus Contribute to the Nitric Oxide-Induced Nociceptive Behavior
Figure 2
Allodynia and hyperalgesia produced by NO donors’ administration underly a PKC-mediated pathway. The PKC blocker calphostin C (calph; 0.2 μg per mouse i.c.v.) reversed cold allodynia (a) and heat hyperalgesia (b) induced by SNP. Calphostin C (c) completely prevented the SNP-induced upregulation of pPKCγ (c) and pPKCε (d) within PAG and thalamus. ,, compared with vehicle-treated control group; , compared with SNP-treated group.